Executive Vice President, Rapid and Molecular Diagnostics · ABBOTT LABORATORIES (ABT)

Andrea Wainer

A named executive officer of ABBOTT LABORATORIES in every fiscal year CompBrief holds from FY2021 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$6,287,118

Salary $710,000Stock awards $2,230,633

FY2021: $7,250,414

5th of 5 named executive officers at Abbott Laboratories by FY2022 total.

5 named officers on file for ABBOTT LABORATORIES, FY2022

Andrea Wainer’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing
  • ABT’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ABBOTT LABORATORIES’s whole pay program stands against its peers

  • ABBOTT LABORATORIES’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ABT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 17, 2023 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Andrea Wainer’s full pay file as a PDF — free

More than this page: up to 10 years of Andrea’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Andrea Wainer compensation by year

ABBOTT LABORATORIES Summary Compensation Table · all 2 fiscal years held
In US dollars, as ABBOTT LABORATORIES reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022
Salary$699,616$710,000
Bonus$0$0
Stock awards$2,388,446$2,230,633
Option awards$2,388,734$2,230,786
Non-equity incentive$931,600$906,300
Pension and deferred compensation$772,906$74,737
All other$69,112$134,662
Total$7,250,414$6,287,118

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ABBOTT LABORATORIES DEF 14A filed March 17, 2023, accession 0001308179-23-000247, and prior-year filings.

How this page was built: the ABBOTT LABORATORIES filed document, accession 0001308179-23-000247. Every figure is read from that document and cited to the page and table it appears in. Filed March 17, 2023.

$7.3M
$6.3M
FY21
FY22
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
PSU18,972$2,082,936—
PSU12,838$1,409,484—
PSU4,525$496,800—
Option88,418—$117.58
Option27,586—$87.72
Option65,806—$124.04

Per the Outstanding Equity Awards at Fiscal Year-End table in ABBOTT LABORATORIES's FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

30 Form 4 lines since the FY2022 proxy (filed March 17, 2023)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2025-03-03Sale—949$138.1774,381
2025-02-28Tax withholding—7,313$135.8775,330
2025-02-25Grant or award derivative—45,730$0.0045,730
2025-02-25Grant or award—12,278$0.0082,643
2024-02-29Tax withholding—8,339$120.0570,365
2024-02-23Exercise or conversion10b5-112,500$59.9491,204
2024-02-23Sale10b5-112,500$120.0078,704
2024-02-23Exercise or conversion derivative10b5-112,500$0.0034,449

The 8 most recent of 30 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

ABBOTT LABORATORIES’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Robert FordChairman of the Board and Chief Executive Officer$21,722,152
Robert FunckExecutive Vice President, Finance and Chief Financial Officer$9,145,220
Daniel SalvadoriExecutive Vice President and Group President, Established Pharmaceuticals and Nutritional Products$7,157,684
Hubert AllenExecutive Vice President, General Counsel and Secretary$7,019,635
Andrea Wainer · this pageExecutive Vice President, Rapid and Molecular Diagnostics$6,287,118

The full ABBOTT LABORATORIES compensation record

free company brief

This page is one person within ABBOTT LABORATORIES's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the ABBOTT LABORATORIES proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ABBOTT LABORATORIES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Andrea Wainer's compensation dossier · One-time report. No refunds.